Spineway S.A.
ALSPW.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | -0.00 | 3.84 | 0.07 |
| FCF Yield | -14.41% | -14,290.08% | -1.16% | -27.08% |
| EV / EBITDA | -3.19 | -0.18 | -434.18 | 0.71 |
| Quality | ||||
| ROIC | -19.05% | -20.58% | -25.26% | -4.65% |
| Gross Margin | 28.13% | 15.45% | 3.19% | -33.71% |
| Cash Conversion Ratio | 0.85 | 0.90 | 0.52 | 1.13 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.15% | 34.85% | 30.05% | -8.42% |
| Free Cash Flow Growth | 55.09% | 47.53% | -382.40% | -107.34% |
| Safety | ||||
| Net Debt / EBITDA | 0.43 | -0.17 | 1.47 | 9.51 |
| Interest Coverage | -2.34 | -4.39 | -168.95 | -20.84 |
| Efficiency | ||||
| Inventory Turnover | 1.82 | 2.02 | 1.83 | 2.38 |
| Cash Conversion Cycle | 259.97 | 169.84 | 163.24 | 219.21 |